Purpose: To investigate microorganisms causing central venous catheter contamination and how this contamination differs across different catheter metrics. Materials and methods: After obtaining IRB approval and informed consent, 830 cultures were prospectively obtained from 45 ICU patients with central venous catheter or peripherally inserted central catheter. Bacterial colonies were identified by mass spectrometry. Results: Bacterial contamination of central catheter hubs occurred 44% of the time in this study in the ICU setting. Coagulase-positive staphylococci cultures had higher median (±interquartile range) CFUs (12 ± 232) versus coagulase-negative (3 ± 10) and other bacteria (1 ± 3; P b 0.001). Bacterial contamination was associated with various metrics. Higher incidence (P b 0.05) of coagulase-positive staphylococci cultures was associated with hub-only connections (a "hub" being a female connection; 10.9% vs. 7.9% male connections), connections without a manifold (1 lumen device that mixes multiple infusions together; 9.7% vs. 0% with manifold); and central venous pressure monitoring connections (25.8% vs. 7.1% without). Internal jugular sites (10.0% vs. 2.7% femoral, 6.2% PICC, P = 0.031) and medial lumens of triple lumen catheters (11.9% vs. 5.6% distal, 7.0% proximal, P = 0.049) had increased incidence of higher bacteria loads (N 15 CFUs). Conclusions: This study found a high incidence of central access catheter hub bacterial contamination, which correlated with positive blood cultures in 2 of 3 total bacteremia cases identified in the 45 patients.
Introduction
Despite diligent healthcare worker efforts and Centers for Disease Control checklist protocols [1] designed to prevent central line-associated blood stream infections (CLABSI), CLABSI remain a problem for hospitals causing patient harm. CLABSI are estimated to cost more than $45,000 per occurrence, and consequences include an average of 10.4 days increase in hospital length of stay [2] .
One of the most common causes of CLABSI is colonization of central venous catheters (CVCs) [3] with sources for this catheter colonization including the catheter hub or the skin surrounding the catheter insertion site [4, 5] . Cultures obtained from short and long-term CVCs either obtained by swabbing the inside of the lumen of catheter hubs (i.e. intraluminal) or by withdrawing fluid from the catheter hub, reveal that central venous catheter colonization is unlikely if cultures obtained from the catheter hubs fail to grow microorganisms [6] [7] [8] [9] . However, the procedure for intraluminal catheter hub culturing in vivo requires entering the hub of the catheter and thus carries the risk for migration of microorganisms into the bloodstream during the process [10, 11] . A recent investigation of short-term CVCs in cardiac surgery intensive care unit ICU patients demonstrated that if CVC needleless hub connector cultures obtained from the external surface of the hub were negative for bacterial growth, CVC colonization was unlikely; external hub culture results were also superior to intraluminal hub cultures to rule out short-term CVC colonization [12] .
Because contamination of CVCs is a common cause of CLABSI, the aim of this study was to determine the extent of external contamination of needleless connectors from CVCs located in various vascular access sites in the ICU setting and how this contamination was related to different catheter metrics. The metrics included use of central venous pressure monitoring, propofol infusion, connector type, the anatomical location of the CVC and for multiple lumen catheters, the location of the lumen from which the sample was obtained. The primary outcome for this study was bacterial contamination, as measured by the number of overall positive cultures, bacterial load (colony forming units, CFUs), and incidence of coagulase positive (COPS) versus coagulase negative (CONS) species within positive cultures. Our hypothesis was that factors associated with more frequent accessing of the CVC needleless connector and the infusion of propofol would be related to an increased incidence of bacterial contamination.
Materials and methods

Study design
After obtaining IRB approval (University of Florida IRB #201200067), 45 patients in the Neuro ICU (NICU) and Burn ICU (BICU) at UF Health Shands Hospital, Gainesville, FL, were enrolled in our prospective cohort study over a period of 4 months from April 2013 to August 2013. Written informed consent was obtained from all subjects or a legal surrogate if the patient was not able to provide consent. This study did not involve the assignment of patients to treatment groups.
Inclusion criteria and patient population
Patients were eligible for enrollment if they had at least one CVC or peripherally inserted central catheter (PICC). The catheter hubs of these CVCs and PICCs were sampled every 24 h for 7 days or until the CVC or PICC was removed or the patient was discharged, whichever occurred first. Of the 45 patients, 29 successfully completed the full 7 days of culturing; the remaining patients had fewer than 7 days of culturing due to CVC or PICC removal. Research personnel were neither involved in decisions for removal of central access nor patient discharge.
Patient catheter culturing technique
Sterile, cotton-tipped applicators (Medline Industries, Inc., Mundelein, IL) moistened with 0.9% NaCl sterile saline solution (Baxter Healthcare Corporation, Deerfield, IL) were used to lightly brush the external surface of the catheter hub; this sampling did not involve entering the hub catheter or any connections to the CVC or PICC (e.g. propofol infusion) (Fig. 1 ). For consistency, the hub proximal to the patient was chosen to obtain cultures if there were multiple needleless connectors. After sampling, the hubs were scrubbed with 70% isopropyl alcohol.
Although sterilizing before access is standard of care, it is unclear if this process is followed every time the CVC or PICC is accessed, so for this study, the needleless hubs were not scrubbed before sampling. Sampling was done by two of the authors (Brenda Fahy, MD and Julie Holroyd, BS). Kenneth Rand, MD Professor and Clinical Pathology and Medicine Director Virology and Bacteriology Director UF Health Shands Hospital trained the investigators on sampling technique. Negative controls were not performed for this study because hubs and stopcocks taken directly from sterile packaging have been shown not to be contaminated with microorganisms [13] .
The type of connector, if present on the central catheter, was recorded. These included a needleless connector with a male connector used to access the female hub of the catheter (Fig. 2) , a manifold, which is a single lumen device with multiple ports that allow several infusions to be mixed together (Fig. 3) , or a stopcock serving as an intravenous connector to join two or more infusions into one with the ability to stop the flow of one of the infusions by turning a handle. Other data recorded included the anatomical location of the CVC and, for multiple lumen CVCs, the location of the lumen from which the sample was obtained was noted. For a CVC with 3 lumens, each proximal, medial (between the proximal and distal), and distal location was recorded as the culture site. During hub culturing, the fluid(s) and/or medication(s) being administered through the hub was recorded. If there was more than one needleless connector attached to the hub, the connector with a medication that had the potential to provide a medium for bacterial growth (e.g., propofol) was preferentially sampled. Central venous catheter lumens utilized for central venous pressure (CVP) monitoring were also sampled and recorded. CVP can be used as a proxy for frequency of catheter access because, at our institution, CVP access is often utilized for intermittent administration of intravenous medications, whereas the other lumens were used for continuous infusions. Insertion data for the CVC was collected including date, anatomic site, (internal jugular, subclavian, femoral, or basilic vein), and hospital location of the patient at the time of insertion.
Throughout the study, clinical staff adhered to the UF protocol for routine care of CVCs and PICCs. During the study period, CVC placement was performed adhering to Centers for Disease Control recommendations [1] , including hand sanitization before insertion, patient skin preparation with 2% chlorhexidine solution, and maximum barrier precautions, including the individual responsible for placement of the CVC wearing a hat and mask, sterile gown and gloves and covering the patient with a sterile full body drape during insertion. In addition, alcohol was used for scrubbing before accessing the needleless catheter hub, and infusion tubing was changed every 72 h, except for propofol, whose medication and infusion tubing was changed every 24 h. No patient during this study received total parenteral nutrition. Clinical practice remained the same during the study period including the techniques for accessing CVCs or PICCs, required timing of intravenous administration set changes, and nurse-to-patient ratio. The BICU policy requires all CVCs and PICCs to be changed every 7 days.
Microbiological techniques
The cotton-tipped applicator swab samples obtained from the external surface of the catheter hubs were streaked across standard 5% sheep blood agar plates immediately after collection and then plates were incubated for a 24 h period at 37°C in air. Individual colonies were identified and counted. Individual colonies cultured on the plates were then cultured again to provide sufficient bacteria to use for identification as described in the next section. When there were too many colonies to count on a plate, the plate was divided into smaller sections; CFUs were counted and then multiplied by the number of sections. This work was performed in the UF Health Shands Hospital clinical microbiology laboratory by one of the authors.
Colony identification
Individual colonies were identified by a mass spectrometer (Vitek MS™, bioMerieux, Inc., Durham, NC) using the Saramis research database and the SuperSpectra and Reference Spectra algorithms. The mass spectrometry method used in this study has been shown to identify colonies with a high degree of accuracy [14, 15] . Colonies were identified by the direct method and, if necessary, the formic acid method as described in the next paragraph.
For the direct method, a sample of the colony to be identified was obtained using a 1 μL calibrated loop to facilitate uniform streaking, and a thin layer was spread over the sample well area of a sterile polymeric slide (FlexiMass polymeric MALDI target; Shimadzu Biotech, Kyoto, Japan). These samples were then covered with 1 μL of α-cyano-4-hydroxycinnamic acid (CHCA) matrix solution. After the matrix dried completely allowing crystallization, the slides were then analyzed by the mass spectrometer to determine the colony type. The direct method was used for initial colony identification, and if the colony was not able to be identified the formic acid method was then utilized.
The formic acid method further purifies the sample's proteins, producing a more precise protein structure to be analyzed by the mass spectrometer. This method involved spreading 1 μL of CHCA matrix over the sample site area of a sterile polymeric slide and then was dried to permit crystallization. One microliter of a bacterial/formic acid suspension containing 10 μL of sterile water, a sample of the bacterial colony, and 10 μL of FA at 25% was then placed on top of the matrix on the slide. After the slide dried again, another 1 μL layer of CHCA matrix was placed on top of the material on the slide. After drying, the slides were then inserted into the mass spectrometer for spectra reading to identify the bacteria genus and species. For both methods, Escherichia coli (ATCC 8739) was used as a control for mass spectrometry calibration.
Data analysis
Continuous measures are reported by medians ± interquartile range and categorical measures are reported as percentages. Differences in incidence of COPS versus CONS and other bacteria, incidence of positive cultures, and the presence of N 15 CFUs across each catheter metric were evaluated using chi-square tests. Secondary analyses were performed to assess the influence of CVC age (2 or fewer days old vs. N2 days old) on the incidence of positive cultures. Differences in overall CFUs across bacteria species were analyzed using the Kruskal-Wallis test. P b 0.05 was considered statistically significant. All analyses were performed in JMP 12.0 (SAS Institute Inc., Cary, NC).
Results
Sample description
A total of n = 830 cultures were analyzed (from 45 patients; 42 NICU and 3 BICU) with sample characteristics reported in Table 1 . The median duration between initial insertion and study culture sampling was 4 days. A majority of patients (82.2%, 37/45) had one central access catheter in place at the time of sampling, with a median of cultures analyzed per catheter of 10. Few hub cultures (b 15%) were obtained from connections involving CVP monitoring or a propofol infusion. A majority of connectors used a male connector to access a female hub (51.0%). There was an even distribution (~30%) for CVC hub sites (proximal vs. medial vs. distal). A majority of CVCs were located in the internal jugular vein (73.6%) and had been in place longer than 2 days when the hubs were cultured (69.6%).
Bacterial characterization of sample cultures
Of the 830 cultures analyzed, 365 (44.0%) of cultures were positive for some type of bacteria, with species identification determined by mass spectroscopy. Specifically, 3.5% of the hubs sampled (29/830) were colonized with COPS, 33.4% (277/830) were colonized with CONS, and 7.1% (59/830) were colonized with other bacteria. Median CFUs (± interquartile range) were higher (χ2 = 19.7, P b 0.001) for the cultures with COPS (12 ± 232) compared to CONS cultures (3 ± 10) and other types of bacteria (1 ± 3). Hub cultures with COPS (44.8%) were also more likely to have N15 CFUs (χ2 = 11.1, P = 0.004) compared to CONS (18.4%) and other bacteria (14.1%).
Relationship between catheter metrics and bacterial contamination
The type of connector to the hub (e.g., manifold; χ2 = 11.4, P = 0.01), anatomical location of the CVC (χ2 = 26.3, P b 0.001), and the CVC hub site (proximal, medial, and distal; χ2 = 6.3, P = 0.04) were all associated with the presence of positive cultures. Specifically, a higher proportion of cultures were positive within CVCs with an internal jugular location, PICCs, and medial hub sites on triple lumen CVCs (Fig. 4) . The proportion of positive cultures did not differ with the administration of propofol (41.5%) compared to other fluids or medications being administered at the time of sampling (36.3%; P = 0.438); however, for central access catheters whose time from placement to sampling was 2 or fewer days, the proportion of positive cultures was higher with the administration of propofol (54.2%) compared to fluid or other medication administration (31.0%; χ2 = 4.9, P = 0.03), but the differences between incidence of positive cultures associated with propofol versus other drugs were attenuated in central access catheters older than 2 days (38.1% vs. 40.6%, respectively, P = 0.754).
In terms of bacteria counts, cultures from internal jugular vein catheter locations (χ2 = 6.9, P = 0.036) and medial hub sites on triple lumen CVCs (χ2 = 9.97, P = 0.007) were more likely to have higher bacteria loads (N15 CFUs), whereas cultures from catheters located in the femoral vein and other catheter hub sites (e.g. distal and proximal) were less likely to have such high bacteria counts (Fig. 5) ; propofol did not increase growth in CFUs (P = 0.904). Among positive cultures (n = 365), needleless hub connector connections (χ2 = 6.4, P = 0.04), connections without a manifold (χ2 = 6.7, P = 0.03), and transducer connections for CVP monitoring (χ2 = 9.6, P = 0.008) were associated with a higher incidence of COPS cultures (Fig. 6) . Notably, no COPS cultures were associated with a manifold connecting infusions to the lumen of the CVC.
Correlation of hub contamination with CLABSI
Three of the 45 participants had positive blood cultures during this study. The microorganisms from the hub cultures were consistent with bacteremia in 2 of the 3 total cases. The first patient's blood culture revealed Acinetobacter baumannii with the proximal port of the triplelumen RIJ catheter in this burn patient culturing 128 CFUs of A. baumannii. This proximal port had a male connector attached to a female hub, and did not have propofol infusing. No hub was present on the medial port, so the outside surface of the lumen where the hub would have connected was swabbed and grew 720 CFUs of A. baumannii; the medial port also did not have propofol infusing. The distal port used for CVP monitoring grew 1 CFU of A. baumannii. The second patient's blood culture revealed Enterococcus faecium; this BICU patient had a triple lumen CVC located in the femoral vein. The medial lumen of the CVC had a male connector attached to a female hub, did not have propofol infusing, and grew 9 CFUs of E. faecium. The proximal and distal ports of this catheter did not have any CFUs on culture. The third patient's blood culture revealed Prototheca wickerhamii; this NICU patient had a triple-lumen CVC located in the right internal jugular vein; Prototheca wickerhamii was not present on any of the hub cultures.
Discussion
This study, examining the extent of bacterial contamination of central venous catheter hubs in the ICU, found a high incidence of catheter hub bacterial contamination. When bacterial contamination was present, CONS was the most common isolate with the highest bacterial counts of all the species isolated. CONS represented a larger percentage of total cultures (32.8%) compared to COPS (3.5%), and catheter hubs that were contaminated with COPS were more likely to have higher bacterial loads (median CFU = 12 ± 232) compared to CONS (median CFU = 3 ± 10). Central venous catheters located in the femoral veins had lower rates of contamination and high bacterial loads when contamination was present (2.7% femoral, 6.2% PICC, 10% internal jugular with N 15 CFUs) compared to those in the internal jugular veins and basilic vein PICCs. Sites with hub-only connectors (a "hub" being a female connection point to a vascular access device; χ2 = 6.4, P = 0.04) and those with CVP monitoring (χ2 = 9.6, P = 0.008) were associated Fig. 4 . Percent of total cultures that were positive for bacteria, stratified by anatomical insertion location and site. with a higher incidence of COPS cultures. There was no difference in CFU counts when propofol was being infused compared to those hubs without propofol when the central venous catheter had been in place for more than 2 days. All CFUs were positively identified by mass spectrometry and correctly identified 2 of the 3 bacteria that were also cultured from the patients' blood. For the two BICU patients, the hub cultures identified Acinetobacter baumannii and E. faecium more than 24 hours and 12 hours respectively before the blood cultures results were available; in each case the medial hub catheter cultures had the highest number of CFUs. In this study, the medial hub was associated with positive cultures as well as higher bacterial counts compared to the proximal or distal hubs for triple lumen CVCs. This is consistent with other studies whose authors theorize that the medial hub location may allow for surface contact from the proximal and distal hubs located on each side that may transfer bacteria [16] . The third patient with the bacteria Prototheca wickerhamii cultured from the blood did not have this microorganism present on any of the catheter hub cultures and may have been from a different source than the CVC.
All catheter hubs from all CVCs and PICCs were cultured in this study. It has been shown that CLABSI will be missed up to 27.2% of the time for double-lumen catheters and 15.8% of the time for triple-lumen catheters if more than one port is not accessed for blood cultures [17] . This is consistent with our findings as the medial hub culture was found to have high CFUs while the proximal and distal hubs of the catheter at times did not reveal the presence of microorganisms. Mass spectrometry was utilized to identify the colonies in this study. Mass spectrometry has a reported accuracy of 90-100% on the genus level, and between 97-98% for Staphylococci and Streptococci; the most common organisms in this study [14, 15] . In a model catheter contamination study, Matrixassisted laser desorption/ionization-time-of-flight (MALDI-TOF) taken directly from deliberately contaminated catheters did not improve the time to detection of colonization compared with conventional culture and identification methods [18] . MALDI-TOF was used to detect growth from patient catheters after 6 and 12 hours incubation in broth and did have good sensitivity compared with conventional methods, such as roll plate and sonication at 24-48 hours; however, it did have high negative predictive value after 12 hour incubation [19] . For our study, we did not attempt to improve the time to detection of colonization of the connector hubs, but followed conventional culture methods in waiting for colony growth before using MSLD-TOF for identification.
Intraluminal catheter colonization remains a significant mechanism for CLABSI in adults requiring prolonged CVCs [20, 21] . The presence of bacteria on cultures from needleless hub connectors has been associated with an increased risk of CLABSI [22] [23] [24] [25] [26] [27] . Other studies suggest needleless connectors may protect against CVC colonization [28] and may thus prevent CLABSI. Risk factors for CLABSI have been identified as inadequate disinfection practices when accessing the catheter hub and the presence of bacteria when CVCs were not being utilized. In our study, all hubs were theoretically sterilized after culturing each day and the extent of re-colonization after a 24-h period could be examined. For quality control of the sterilization process, we ran analyses to assess if the same bacterial species was found in culture from the same patient on consecutive days, which would indicate a failure to sterilize. There was no statistically significant association between bacterial species cultured on consecutive days, supporting the sterilization of the hubs after each culture (χ2 = 2.56, P = 0.862).
Current recommendations [1] for the care of central access catheters involve scrubbing the needleless connector hubs with one of three recommended antiseptics: chlorhexidine, povidone iodine, or alcohol; all have been shown to reduce CONS when scrubbing is used as the disinfection technique [29] . Wiping as a disinfection technique has been shown to reduce CONS, however, it was less effective than scrubbing [30] . Bacteria-contaminated catheter hubs have been shown to present CONS as the most frequent pathogens [31, 32] , with recent studies showing the patients' skin is often the reservoir for COPS bacterial transmission [33] .
In our study, the outside surface of the CVC lumen used to transduce CVP showed the highest incidence of contamination compared to other lumens. The CVP access at our institution is often utilized for intermittent administration of intravenous medications, whereas the other lumens were used for continuous infusions (e.g., propofol, vasoactive medications). Frequent access for intermittent medication administration through catheter hubs is a risk factor for CLABSI [34] [35] [36] and likely explains the higher CFU rates on the central venous pressure lumen in our study.
Lipids have been shown to support bacterial growth [37] and, interestingly in this study, while the hubs cultured during propofol (a soybean oil-based product and lipid vehicle) infusion did not show an overall higher incidence of CFUs, upon stratifying the sample by day of catheter placement, those catheters 2 or fewer days since placement with propofol were associated with a higher incidence of microorganisms when hubs were cultured. Propofol has been shown to increase bacterial contamination [38] with faster growth than saline [39] , and is associated with a risk of ICU-acquired infection and sepsis [40] . To decrease the infectious risks of propofol at UF Health, all components associated with the propofol infusion including the bottle containing propofol and all intravenous administration sets are changed frequently and propofol requires a dedicated lumen of the CVC for continuous infusion. These measures may have prevented infection in CVCs with more than 2 days since placement.
The amount of time from the catheter placement to hub bacterial growth was analyzed; PICCs, which are designed for longer-term use, had higher proportions of microorganisms cultured in this study. Longer-term catheters are more likely to have an intraluminal source of infection [41] , whereas shorter-term catheters are more likely to have an extraluminal infection source [42] . A higher risk has been shown for catheters used for longer than 10 days, perhaps reflecting catheter hub contamination from the number of times the hub was accessed [43, 44] . Compared to CVCs, PICC have a significantly longer time until the development of infection [45] .
Several previous studies have shown a higher rate of CLABSI with CVCs located in the femoral vein [46] or internal jugular vein [35] compared to the subclavian vein, with the hypothesis that there is less cutaneous colonization located at the subclavian site [47] . In our study, CVCs located in the internal jugular vein had a higher incidence of hub catheter bacteria than those located in the subclavian or femoral veins, which may be related to the number of cultures from each site. A meta-analysis examining infection risk with location of CVCs [48] showed in earlier studies a higher risk of infection with a femoral vein CVC; however more recent studies found no differences in infection risk when comparing femoral, internal jugular, and subclavian vein CVC locations [48] . A 2012 Cochrane analysis recommended subclavian vein locations rather than femoral vein locations for CVCs due to the higher risk of catheter colonization with the femoral vein location; however, there was no difference between the femoral and internal jugular vein locations for CVCs rate of catheter colonization [49] . A recent multicenter study [7] showed a lower incidence of CLABSI with CVCs located in a subclavian vein compared to femoral or internal jugular vein locations. Due to infection concerns, internal jugular and subclavian veins are preferred locations for CVC placement compared to the femoral veins at UF Health. When a CVC is placed in the femoral vein and there is a continued requirement for CVC placement, the site is changed to either the internal jugular vein or subclavian vein for CVC or to a PICC as soon as feasible.
Our sample contained only three burn patients, all of whom had bacterial contamination associated with CVCs. In burn patients with CVCs, the source of CLABSI has been shown to result from an extraluminal site, as skin bacteria contiguous to the catheter insertion site allow the microorganism to invade the catheter [39] . In addition, in 1346 CVCs investigated from 1183 burn patients over a 5-year period, the bacteria responsible for CLABSI were COPS (30.6%), Pseudomonas aeruginosa (18.1%), and Acinetobacter species (13.5%) [40] . Our small sample of burn patients did not allow further analysis; there was, however, one documented Acinetobacter hub colonization. The 45 NICU and 3 BICU patients included were not intended to represent other patients from different ICUs who may constitute different characteristics, and we consider this a limitation of the study's applicability. Study limitations due to mass spectrometry identification including its difficulty in distinguishing between two closely related species, E. coli and Shigella, identification limited to the mass spectrometry database which may present a problem when testing for rare species, and mass spectrometry's inability to provide the organism's susceptibility compared to conventional culture techniques which provide organism susceptibilities.
Conclusions
In summary, bacterial contamination of CVC hubs in this study occurred 44% of the time in the ICU setting, which correlated to 2 of 3 total patients with bacteria identified via blood cultures from all 45 patients during the study. Although CONS represented the majority of the organism isolates, COPS was associated with higher bacterial counts. Bacteria present on the hub catheter may have the ability to cause CLABSI, as suggested by the findings in this study, and requires further study. Initiating a program of high vigilance for sterilizing access ports on each and every occasion is a necessary first step in preventing CLABSI.
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